---
title: "Phase 3 Trial of Chemoradiotherapy With Temozolomide Plus Nivolumab or Placebo for Newly Diagnosed Glioblastoma With Methylated MGMT Promoter."
date: 2022-05-06
enddate:
---

Published in: *Neuro-oncology*

DOI: [10.1093/neuonc/noac116](https://doi.org/10.1093/neuonc/noac116)

This article is not available in Open Access


